Structural insights into the complex of oncogenic KRas4B^G12V and Rgl2, a RalA/B activator.

Area of Science:

• Molecular Biology
• Structural Biology
• Cancer Research

Background:

• Ras isoforms are frequently mutated in human cancers.
• Ral guanine nucleotide exchange factors (RalGEFs) are key activators of RalA and RalB small GTPases.
• RalGEFs play a crucial role in oncogenic Ras-induced signaling pathways.

Purpose of the Study:

• To investigate the interaction between human KRas4B and the Ras association (RA) domain of Rgl2 (Rgl2^RA).
• To elucidate the structural basis of the interaction between oncogenic KRas4B^G12V and Rgl2^RA.
• To understand the mechanism by which KRas4B^G12V hyperactivates the RalA/B pathway.

Main Methods:

• Studied the interaction kinetics between human KRas4B and Rgl2^RA.
• Determined the crystal structure of the KRas4B^G12V: Rgl2^RA complex.
• Compared the structural arrangement with known Ras:effector complexes.

Main Results:

• The G12V oncogenic KRas4B mutation alters interaction kinetics with Rgl2^RA.
• The crystal structure revealed a 2:2 heterotetramer of KRas4B^G12V: Rgl2^RA.
• The G12V mutation was located at the dimer interface of KRas4B^G12V, suggesting a distinct binding mode compared to Ras:Raf complexes.

Conclusions:

• RalGEFs may form Ras:effector complexes via a distinct mechanism.
• The structural findings provide a mechanistic explanation for oncogenic KRas4B^G12V-mediated hyperactivation of the RalA/B pathway.
• This study sheds light on the molecular basis of oncogenic Ras signaling in cancer.